Healthcare - Biotechnology - NASDAQ - US
$ 2.05
-13.1 %
$ 138 M
Market Cap
-0.64
P/E
Price Target
Average
217.07%
Revenue Forecast
Estimate
360.50%
EBIT
Estimate
--55.39%
Net Income
Estimate
20.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inhibikase Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for IKT of $6.5 , with forecasts ranging from a low of $5 to a high of $8 .
IKT Lowest Price Target
Wall Street Target
5 USD
143.90%
IKT Average Price Target
Wall Street Target
6.5 USD
217.07%
IKT Highest Price Target
Wall Street Target
8 USD
290.24%
REVENUE FORECAST
Revenue Forecast Chart IKT
EBIT FORECAST
EBIT Forecast Chart IKT
NET INCOME FORECAST
Net Income Chart IKT